References
- Abotorabi H (2002): The ethnobotany and phytochemistry of plant distributed in the northern part of Iran in the Roeen and Esfarayen regions. Pharm.D. thesis, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Fidler IJ (1997): Molecular biology of cancer: Invasion and metastasis. In: DeVita VT, Jr, Hellman S, Rosenberg SA, eds., Cancer Principles and Practice of Oncology. Philadelphia, Lippincott–Raven, pp. 135–152.
- Heath EI, Grochow LB (2000): Clinical potential of matrix metalloprotease in cancer therapy. Drugs 59: 1043–1055. [INFOTRIEVE], [CSA]
- Heussen C, Dowdle EB (1980): Electrophoretic analysis of plasminogen activator in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Chem 102: 196–202. [CSA]
- John A, Tuszynski G (2001): The role of matrix metalloproteinase in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14–23. [INFOTRIEVE], [CSA]
- Jones L, Ghaneh P, Humphreys M, Neoptolemos JP (1999): The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann NY Acad Sci 880: 288–307. [INFOTRIEVE], [CROSSREF], [CSA]
- Nguyen M, Arkell J, Jackson CJ (2001): Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33: 960–970. [INFOTRIEVE], [CROSSREF], [CSA]
- Saadat F, Zomorodian K, Pezeshki M, Khorramizadeh MR (2003): The potential role of nonsteroidal anti-inflammatory drugs (NSAIDS) in chemopreventation of cancer. Pak J Med Sci 19: 13–17. [CSA]
- Sadowski T, Steinmeyer J (2001): Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1. Inflamm Res 50: 175–182. [INFOTRIEVE], [CROSSREF], [CSA]
- Stetler-Stevenson WG, Hewitt R, Corcoran M (1996): Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin Cancer Biol 7: 147–154. [INFOTRIEVE], [CROSSREF], [CSA]